Suppr超能文献

利用产碱甲基杆菌和混合盐生古菌从升级沼气中系统比较四氢嘧啶的生产。

A systematic comparison of ectoine production from upgraded biogas using Methylomicrobium alcaliphilum and a mixed haloalkaliphilic consortium.

机构信息

Laboratory of Microbiology, Wageningen University and Research Center, The Netherlands.

Department of Microbiology, Cornell University, Ithaca, NY 14853, USA.

出版信息

Waste Manag. 2020 Feb 1;102:773-781. doi: 10.1016/j.wasman.2019.11.043. Epub 2019 Dec 5.

Abstract

Biogas is the byproduct of anaerobic digestion with the highest valorization potential, however its full exploitation is limited by the lack of tax incentives and the inherent presence of pollutants. The development of technologies for biogas conversion into added-value products is crucial in order to ensure the competitiveness of this bioresource. This study constitutes the first proof of concept of upgraded biogas bioconversion into the high profit margin product ectoine. Ectoine represents the most expensive product synthesized by microorganisms with a retail value of 1000 $ kg and a yearly increasing demand that currently entails a total market opportunity of 15000 M€. First, the production of ectoine from upgraded biogas was assessed in batch bioreactors. The presence of HS did not exert a negative effect on the growth of the haloalkaliphilic ectoine producers, and ectoine yields up to 49 mg g biomass were obtained. A second experiment conducted in continuous bubble column bioreactors confirmed the feasibility of the process under continuous mode (with ectoine yields of 109 mg g biomass). Finally, this study revealed that the removal of toxic compounds (i.e. medium dilution rate of 0.5 day) and process operation with a consortium composed of methylotrophic/non-methylotrophic ectoine producers enhanced upgraded biogas bioconversion. This research discloses the basis for the application of this innovative technology and could boost the economic performance of anaerobic digestion.

摘要

沼气是厌氧消化的副产品,具有最高的增值潜力,但由于缺乏税收激励和污染物的固有存在,其充分利用受到限制。为了确保这种生物资源的竞争力,开发将沼气转化为增值产品的技术至关重要。本研究首次证明了将升级后的沼气生物转化为高利润边际产品——章鱼胺的概念。章鱼胺是微生物合成的最昂贵的产品,零售价为 1000 美元/千克,年需求量不断增加,目前的总市场机会为 15000 万欧元。首先,在分批生物反应器中评估了从升级后的沼气中生产章鱼胺。HS 的存在并没有对耐盐碱性章鱼胺生产者的生长产生负面影响,并且获得了高达 49mg/g 生物质的章鱼胺产量。在连续鼓泡柱生物反应器中进行的第二项实验证实了该过程在连续模式下的可行性(获得了 109mg/g 生物质的章鱼胺产量)。最后,本研究表明,有毒化合物的去除(即介质稀释率为 0.5 天)和由甲基营养型/非甲基营养型章鱼胺生产者组成的联合体进行的过程操作增强了升级后的沼气生物转化。这项研究揭示了应用这项创新技术的基础,并可以提高厌氧消化的经济性能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验